Ken Fisher Acadia Pharmaceuticals Inc Transaction History
Fisher Asset Management, LLC
- $229 Billion
- Q2 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 162,619 shares of ACAD stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
162,619
Previous 152,930
6.34%
Holding current value
$2.49 Million
Previous $2.83 Million
6.54%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ACAD
# of Institutions
288Shares Held
161MCall Options Held
723KPut Options Held
257K-
Baker Bros. Advisors LP New York, NY42.9MShares$656 Million9.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$210 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$210 Million3.72% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$185 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$88.8 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.48B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...